BioCentury
ARTICLE | Company News

Genzyme, ViaCell deal

March 21, 2005 8:00 AM UTC

GENZ will use VIAC's adult islet stem cells in preclinical diabetes studies. GENZ also will study methods of improving production of the cells. Financial terms were not disclosed. ...